Anzeige
❌
Mehr »
Samstag, 10.10.2026 - Börsentäglich über 12.000 News
Elevate Sercive Group: Neue Expertise für den nächsten Wachstumsschritt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
CS

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.09.CV Sciences, Inc.: CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework563Legislation delays implementation of new federal hemp restrictions until December 11, 2026, preserving continued access to naturally derived hemp products SAN DIEGO, CA / ACCESS Newswire / September...
► Artikel lesen
CV SCIENCES Aktie jetzt für 0€ handeln
14.08.CV Sciences outlines hemp-rule delay to December 11, 2026 while expanding PlusHLTH.com and planning multiple 2026 launches1
13.08.CV Sciences Q2 2026 Earnings Call Transcript1
13.08.CV Sciences, Inc. - 10-Q, Quarterly Report1
13.08.CV Sciences Non-GAAP EPS of $0.00, revenue of $2.99M1
13.08.CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results374SAN DIEGO, CA / ACCESS Newswire / August 13, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
12.08.CV Sciences, Inc.: CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids697New digital destination brings the Company's Health Intelligence approach to life, helping consumers better understand their needs, discover science-backed solutions, and navigate healthy aging. SAN...
► Artikel lesen
11.08.CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026619SAN DIEGO, CA / ACCESS Newswire / August 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.06.CV Sciences, Inc.: CV Sciences Expands +PlusHLTH Portfolio with Personalized Wellness Solutions for Healthy Aging779Built on the Company's Health Intelligence Approach, the New Products Help Consumers Create Personalized Wellness Routines That Support Overall Health and Long-Term Vitality SAN DIEGO, CA / ACCESS Newswire...
► Artikel lesen
04.06.CV Sciences, Inc. - 8-K, Current Report2
15.05.Cv Sciences outlines CMS program allowing up to $500 annually in hemp-derived products as it targets positive cash flow in H2 20263
14.05.CV Sciences Reports Q1 2026 Results: Full Earnings Call Transcript2
14.05.CV Sciences GAAP EPS of $0.00, revenue of $3.2M2
14.05.CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results364SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
13.05.CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026622SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.03.CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results644SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
24.03.CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026479SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
10.03.CV Sciences, Inc.: CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth554SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven,...
► Artikel lesen
26.02.CV Sciences, Inc.: CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness506With 20g of clean protein, 5g of creatine, and LactoSpore probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutrition...
► Artikel lesen
23.12.25CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD770SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1